https://www.selleckchem.com/pr....oducts/Phenformin-hy
An amendment to this paper has been published and can be accessed via a link at the top of the paper.CRISPR-Cas technologies have enabled programmable gene editing in eukaryotes and prokaryotes. However, the leading Cas9 and Cas12a enzymes are limited in their ability to make large deletions. Here, we used the processive nuclease Cas3, together with a minimal Type I-C Cascade-based system for targeted genome engineering in bacteria. DNA cleavage guided by a single CRISPR RNA generated large deletions (7-424 kilobases) i
Like
Comment
Share
